Back to search
Melanocortin Obesity Syndrome
Clinical trial pipeline · Data from ClinicalTrials.gov
See which Melanocortin Obesity Syndrome trials you may qualify forClinical trial pipeline · Data from ClinicalTrials.gov
See which Melanocortin Obesity Syndrome trials you may qualify forThis is a Phase 2, open-label study designed to assess the safety and efficacy of setmelanotide in patients with obesity due to Prader-Willi Syndrome (PWS) who…
This is a phase 2 randomized placebo-controlled crossover trial to determine the safety and efficacy of atomoxetine for treating obesity caused by loss-of-funct…
The purpose of the study was to determine the effect of setmelanotide (RM-493) on weight, hunger assessments, and other factors in participants with rare geneti…